FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2547360291> ?p ?o ?g. }

• W2547360291 endingPage "1047" @default.
• W2547360291 startingPage "1039" @default.
• W2547360291 abstract "Aims Rifampicin represents the key antibiotic for the management of osteoarticular infections. An important pharmacokinetic variability has already been described, particularly for absorption and metabolism. All previous pharmacokinetic studies have been focused only on patients treated for tuberculosis. The objective of the present study was to describe a population pharmacokinetic model of rifampicin in patients with staphylococcal osteoarticular infections, which has not been investigated to date. Method Rifampicin concentrations were collected retrospectively from 62 patients treated with oral rifampicin 300 mg three times daily. Plasma concentration–time data were analysed using NONMEM to estimate population pharmacokinetic parameters. Demographic data, infection characteristics and antibiotics taken in addition to rifampicin antibiotics were investigated as covariates. Results A one‐compartment model, coupled to a transit absorption model, best described the rifampicin data. Fusidic acid coadministration was identified as a covariate in rifampicin pharmacokinetic parameters. The apparent clearance and apparent central volume of distribution mean values [95% confidence interval (CI)] were 5.1 1 h –1 (1.2, 8.2 1 h –1 )/23.8 l (8.9, 38.7 l) and 13.7 1 h –1 (10.6, 18.0 1 h –1 )/61.1 1 (40.8, 129.0 1) for patients with and without administration of fusidic acid, respectively. Interindividual variability (95% CI) in the apparent clearance and apparent central volume of distribution were 72.9% (49.5, 86.0%) and 59.1% (5.5, 105.4%), respectively. Residual variability was 2.3 mg l –1 (1.6, 2.6 mg l –1 ). Conclusion We developed the first population pharmacokinetic model of rifampicin in patients with osteoarticular infections. Our model demonstrated that fusidic acid affects rifampicin pharmacokinetics, leading to potential high drug exposure. This finding suggests that fusidic acid dosing regimens should be reconsidered." @default.
• W2547360291 created "2016-11-11" @default.
• W2547360291 creator A5010505408 @default.
• W2547360291 creator A5025691127 @default.
• W2547360291 creator A5068608250 @default.
• W2547360291 creator A5071522038 @default.
• W2547360291 creator A5086914602 @default.
• W2547360291 creator A5087380286 @default.
• W2547360291 date "2017-01-16" @default.
• W2547360291 modified "2023-10-18" @default.
• W2547360291 title "Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid" @default.
• W2547360291 cites W1500104844 @default.
• W2547360291 cites W1577593351 @default.
• W2547360291 cites W1894222875 @default.
• W2547360291 cites W1897893296 @default.
• W2547360291 cites W1983255179 @default.
• W2547360291 cites W1999521622 @default.
• W2547360291 cites W2002400251 @default.
• W2547360291 cites W2005966874 @default.
• W2547360291 cites W2006583270 @default.
• W2547360291 cites W2011120498 @default.
• W2547360291 cites W2013922963 @default.
• W2547360291 cites W2033925955 @default.
• W2547360291 cites W2042212523 @default.
• W2547360291 cites W2045082002 @default.
• W2547360291 cites W2049674476 @default.
• W2547360291 cites W2058780727 @default.
• W2547360291 cites W2067420277 @default.
• W2547360291 cites W2075621134 @default.
• W2547360291 cites W2076191577 @default.
• W2547360291 cites W2094738707 @default.
• W2547360291 cites W2119245748 @default.
• W2547360291 cites W2127140200 @default.
• W2547360291 cites W2130261670 @default.
• W2547360291 cites W2133736791 @default.
• W2547360291 cites W2142486974 @default.
• W2547360291 cites W2149849113 @default.
• W2547360291 cites W2163581302 @default.
• W2547360291 cites W2164842502 @default.
• W2547360291 cites W2194756172 @default.
• W2547360291 cites W2196064518 @default.
• W2547360291 cites W2423060852 @default.
• W2547360291 doi "https://doi.org/10.1111/bcp.13178" @default.
• W2547360291 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5401979" @default.
• W2547360291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27813241" @default.
• W2547360291 hasPublicationYear "2017" @default.
• W2547360291 type Work @default.
• W2547360291 sameAs 2547360291 @default.
• W2547360291 citedByCount "10" @default.
• W2547360291 countsByYear W25473602912017 @default.
• W2547360291 countsByYear W25473602912018 @default.
• W2547360291 countsByYear W25473602912019 @default.
• W2547360291 countsByYear W25473602912020 @default.
• W2547360291 countsByYear W25473602912022 @default.
• W2547360291 crossrefType "journal-article" @default.
• W2547360291 hasAuthorship W2547360291A5010505408 @default.
• W2547360291 hasAuthorship W2547360291A5025691127 @default.
• W2547360291 hasAuthorship W2547360291A5068608250 @default.
• W2547360291 hasAuthorship W2547360291A5071522038 @default.
• W2547360291 hasAuthorship W2547360291A5086914602 @default.
• W2547360291 hasAuthorship W2547360291A5087380286 @default.
• W2547360291 hasBestOaLocation W25473602911 @default.
• W2547360291 hasConcept C112705442 @default.
• W2547360291 hasConcept C126322002 @default.
• W2547360291 hasConcept C139254425 @default.
• W2547360291 hasConcept C142724271 @default.
• W2547360291 hasConcept C2776239304 @default.
• W2547360291 hasConcept C2778607973 @default.
• W2547360291 hasConcept C2779489039 @default.
• W2547360291 hasConcept C2780483375 @default.
• W2547360291 hasConcept C2781069245 @default.
• W2547360291 hasConcept C2908647359 @default.
• W2547360291 hasConcept C3019249092 @default.
• W2547360291 hasConcept C501593827 @default.
• W2547360291 hasConcept C523546767 @default.
• W2547360291 hasConcept C54355233 @default.
• W2547360291 hasConcept C71924100 @default.
• W2547360291 hasConcept C86803240 @default.
• W2547360291 hasConcept C89423630 @default.
• W2547360291 hasConcept C98274493 @default.
• W2547360291 hasConcept C99454951 @default.
• W2547360291 hasConceptScore W2547360291C112705442 @default.
• W2547360291 hasConceptScore W2547360291C126322002 @default.
• W2547360291 hasConceptScore W2547360291C139254425 @default.
• W2547360291 hasConceptScore W2547360291C142724271 @default.
• W2547360291 hasConceptScore W2547360291C2776239304 @default.
• W2547360291 hasConceptScore W2547360291C2778607973 @default.
• W2547360291 hasConceptScore W2547360291C2779489039 @default.
• W2547360291 hasConceptScore W2547360291C2780483375 @default.
• W2547360291 hasConceptScore W2547360291C2781069245 @default.
• W2547360291 hasConceptScore W2547360291C2908647359 @default.
• W2547360291 hasConceptScore W2547360291C3019249092 @default.
• W2547360291 hasConceptScore W2547360291C501593827 @default.
• W2547360291 hasConceptScore W2547360291C523546767 @default.
• W2547360291 hasConceptScore W2547360291C54355233 @default.
• W2547360291 hasConceptScore W2547360291C71924100 @default.
• W2547360291 hasConceptScore W2547360291C86803240 @default.
• W2547360291 hasConceptScore W2547360291C89423630 @default.

• next